Table 3.

Identification of Serum Biomarkers for Prediction of Major Depression Before Disease Onset.

The table shows the molecular pathways and specific molecules covered by these tests as well as the associated publications

Molecular pathway	Analyte	Publication
Inflammation	Carcinoembryonic antigen	Haenisch et al., 2015
	CD5	Haenisch et al., 2015
	CD40	Haenisch et al., 2015
	Cystatin C	Haenisch et al., 2015
	ENRAGE	Haenisch et al., 2015
	Growth-regulated alpha protein	Haenisch et al., 2015
	Interleukin-1 receptor antagonist	Haenisch et al., 2015
	Interleukin-10	Haenisch et al., 2015
	Macrophage inflammatory protein-1 beta	Haenisch et al., 2015
	Matrix metalloproteinase-3	Haenisch et al., 2015
	Matrix metalloproteinase-7	Haenisch et al., 2015
	Matrix metalloproteinase-9, total	Haenisch et al., 2015
	Receptor for advanced glycosylation end products	Haenisch et al., 2015
	Serum amyloid P-component	Haenisch et al., 2015
	Tumor necrosis factor receptor-Like 2
Growth factor signalling	Hepatocyte growth factor	Haenisch et al., 2015
Lipid transport	Apolipoprotein A1	Haenisch et al., 2015
	Apolipoprotein A2	Haenisch et al., 2015
	Lipoprotein (a)	Haenisch et al., 2015